Further, highlighting the pro-thrombotic nature of the stenotic valve, this study confirmed the presence of tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1), reinforcing earlier findings that suggest the aortic stenotic valve is a contributor to systemic thromboembolic risk, including stroke [60]. The gene discussed is SERPINE1; the disease is stroke disorder.